Cancer-associated retinopathy after anti-programmed death 1 (PD-1) antibody for treating hepatocellular carcinoma——a case report of a Chinese patient

PURPOSE: Programmed death-1 (PD-1) receptor antibody immune therapy has been widely used for treating solid tumors, and cancer-associated retinopathy after the anti-PD1 treatment have not been reported yet. We report a Chinese patient presenting with acute constriction of visual fields after nivolum...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qian, Feng, Chaoyi, Sun, Chuanbin, Wang, Wenji, Wang, Min, Chen, Ling, Sun, Xinghuai, Tian, Guohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859810/
https://www.ncbi.nlm.nih.gov/pubmed/35243142
http://dx.doi.org/10.1016/j.ajoc.2022.101370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859810/
https://www.ncbi.nlm.nih.gov/pubmed/35243142
http://dx.doi.org/10.1016/j.ajoc.2022.101370

Ejemplares similares